论文信息 - CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900. - 字舞流文

CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900.

M. Gönen | O. Abdel-Wahab | A. Melnick | M. Figueroa | R. Levine | M. Tallman | E. Paietta | J. Racevskis | J. Rowe | Zhuoxin Sun | R. Ketterling | H. Fernandez | Jay P. Patel | R. Levine